Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Saved in:
| Title: | Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. |
|---|---|
| Authors: | Vogel VG (AUTHOR), Costantino JP (AUTHOR), Wickerham DL (AUTHOR), Cronin WM (AUTHOR), Cecchini RS (AUTHOR), Atkins JN (AUTHOR), Bevers TB (AUTHOR), Fehrenbacher L (AUTHOR), Pajon ER Jr. (AUTHOR), Wade JL III (AUTHOR), Robidoux A (AUTHOR), Margolese RG (AUTHOR), James J (AUTHOR), Lippman SM (AUTHOR), Runowicz CD (AUTHOR), Ganz PA (AUTHOR), Reis SE (AUTHOR), McCaskill-Stevens W (AUTHOR), Ford LG (AUTHOR), Jordan VC (AUTHOR) |
| Source: | JAMA: Journal of the American Medical Association. 6/21/2006, Vol. 295 Issue 23, p2727-2741. 15p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00987484 |
|---|---|
| DOI: | 10.1001/jama.295.23.joc60074 |
